The FDA has approved a new drug, zanidatamab, for adults with advanced biliary tract cancer, or BTC. Marketed under the brand name Ziihera, it is a first-of-a-kind treatment for patients with ...

A group of researchers is drawing scientific attention to “seasonal psychology,” revealing useful new ways to improve your mental and physical health, especially in winter.

Of course, many Americans now work from home (or hybrid-style). But dozens of other at-home activities are also on the rise, according to new survey data from the U.S. Census program. For the average ...

The FDA has granted fast-track approval for a groundbreaking gene therapy indicated for a rare genetic disorder called ...

The critical key to weight loss success? Sustainability. No single diet or plan works for everybody, but a secret formula does exist – and it’s unique to you.

About 6 in 10 people say they probably won’t get an updated shot this year, despite the CDC’s recommendation that everyone do so, according to results of a new survey from the Pew Research Center.

The FDA has approved a new drug called revumenib that can be taken orally to treat acute leukemia in patients 1 year or older. The drug will be marketed under the brand name Revuforj.

More than half of U.S. adults now qualify to take semaglutide, the popular diabetes and weight loss drug sold under the brand names Ozempic and Wegovy.